NASDAQ · CVKD

Cadrenal Therapeutics, Inc.

Closing price · Nov 13, 2026 $1.51

Latest quarter · ended Jun 30, 2026

Cash got weaker

descriptionFiled Aug 13, 2026
Cash from operationsBetter
−$2.23M
Quarter ended Sep 30, 2024: −$2.2M cash from operationsQuarter ended Dec 31, 2024: −$1.79M cash from operationsQuarter ended Mar 31, 2025: −$4.65M cash from operationsQuarter ended Jun 30, 2025: −$3.03M cash from operationsQuarter ended Sep 30, 2025: −$2.36M cash from operationsQuarter ended Dec 31, 2025: −$2.57M cash from operationsQuarter ended Mar 31, 2026: −$3M cash from operationsQuarter ended Jun 30, 2026: −$2.23M cash from operations
Sep '24Jun '26
vs. −$3.03M a year ago
Share countDiluting
+74.3%
Quarter ended Sep 30, 2024: 1.66M sharesQuarter ended Dec 31, 2024: 1.88M sharesQuarter ended Mar 31, 2025: 1.97M sharesQuarter ended Jun 30, 2025: 2.05M sharesQuarter ended Sep 30, 2025: 2.08M sharesQuarter ended Dec 31, 2025: 2.51M sharesQuarter ended Mar 31, 2026: 2.87M sharesQuarter ended Jun 30, 2026: 3.57M shares
Sep '24Jun '26
3.57M shares vs. 2.05M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Mixed Insiders: as of Nov 13 Funds: as of Jun 30, 2026
−1000+100 0
  • info
    3 real insider sales in 12 months. $70.4K in total, not counting planned sales.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

18 funds report owning CVKD, up from 16

Holdings as of Jun 30, 2026
New7
Added4
Held6
Trimmed1
Sold out5

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale
CEOCFOOther officersDirectorsDecJanFebMarAprMayJunJulAugSepOctNovPlanned sale (10b5-1) · Dec 29 · $69.2KPlanned sale (10b5-1) · May 11 · $37.3KPlanned sale (10b5-1) · May 12 · $17.4KPlanned sale (10b5-1) · May 22 · $6.63KPlanned sale (10b5-1) · May 28 · $14.7KPlanned sale (10b5-1) · May 29 · $1.52KPlanned sale (10b5-1) · Jun 2 · $1.56KPlanned sale (10b5-1) · Jun 3 · $9.9KPlanned sale (10b5-1) · Jun 4 · $17.2KPlanned sale (10b5-1) · Jun 5 · $9.12KPlanned sale (10b5-1) · Jun 8 · $25.8KPlanned sale (10b5-1) · Jun 9 · $52.7KPlanned sale (10b5-1) · Jun 10 · $14.7KPlanned sale (10b5-1) · Jun 16 · $11.5KPlanned sale (10b5-1) · Jun 17 · $1.62KPlanned sale (10b5-1) · Jun 22 · $32.5KPlanned sale (10b5-1) · Jun 23 · $7.29KPlanned sale (10b5-1) · Jun 25 · $6.38KPlanned sale (10b5-1) · Jun 26 · $27.5KPlanned sale (10b5-1) · Jun 29 · $22.4KOpen-market sale · Jun 11 · $6.02KOpen-market sale · Jun 12 · $51.2KOpen-market sale · Jun 15 · $13.1K
CEOCFOOther officersDirectorsJunJulAugSepOctNovPlanned sale (10b5-1) · Jun 2 · $1.56KPlanned sale (10b5-1) · Jun 3 · $9.9KPlanned sale (10b5-1) · Jun 4 · $17.2KPlanned sale (10b5-1) · Jun 5 · $9.12KPlanned sale (10b5-1) · Jun 8 · $25.8KPlanned sale (10b5-1) · Jun 9 · $52.7KPlanned sale (10b5-1) · Jun 10 · $14.7KPlanned sale (10b5-1) · Jun 16 · $11.5KPlanned sale (10b5-1) · Jun 17 · $1.62KPlanned sale (10b5-1) · Jun 22 · $32.5KPlanned sale (10b5-1) · Jun 23 · $7.29KPlanned sale (10b5-1) · Jun 25 · $6.38KPlanned sale (10b5-1) · Jun 26 · $27.5KPlanned sale (10b5-1) · Jun 29 · $22.4KOpen-market sale · Jun 11 · $6.02KOpen-market sale · Jun 12 · $51.2KOpen-market sale · Jun 15 · $13.1K

Last 6 months. A wider screen shows 12.

Showing 3 real trades. Hidden: 20 planned 10b5-1 sales. Those happen on a schedule and say little about what an insider thinks. Bigger dot means a bigger trade.

Real trades, newest first

Jun 15 Quang Pham Chairman, CEO and Interim CFO, Director, 10% owner Open-market sale $13.1K 3,666 sh at $3.58 Sold 3% of stake
Jun 12 Quang Pham Chairman, CEO and Interim CFO, Director, 10% owner Open-market sale $51.2K 12,996 sh at $3.94 Sold 9% of stake
Jun 11 Quang Pham Chairman, CEO and Interim CFO, Director, 10% owner Open-market sale $6.02K 1,462 sh at $4.12 Sold 1% of stake

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in CVKD

As of Jun 30, 2026
FundOwnsValueChange
Vanguard Capital Management LLC1.4%$167K+11%
HRT Financial LP0.8%$97KNew
Geode Capital Management, LLC0.5%$63.5K−12%
Vanguard Fiduciary Trust Co0.2%$27.8KSame
Tower Research Capital LLC (trc)<0.1%$4.28K+226%

"Owns" is shares reported divided by shares outstanding.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist